Evidence brief
MOTS-c: Mitochondrial-peptide research and human-evidence limits
This research brief explains the difference between observational human work and intervention evidence. It does not provide exercise, treatment, or product advice.
Evidence maturity: preclinical research dominates; human intervention evidence remains limited.
Human evidence
The cited work includes human observational and translational context, not an established clinical use of administered MOTS-c. Association findings do not establish benefit or safety from a product.
Preclinical context
Experimental work investigates mitochondrial-derived peptide signaling and metabolic pathways. These hypotheses require separate human outcome research.
What remains unknown
Large randomized trials, long-term safety information, standardized preparations, and clinically validated indications remain absent from the cited evidence base.
Human-evidence table
A structured reading aid, not a treatment or product decision tool.
| Evidence maturity | Human-study context | Interpretation limit |
|---|---|---|
| preclinical research dominates; human intervention evidence remains limited. | The cited work includes human observational and translational context, not an established clinical use of administered MOTS-c. Association findings do not establish benefit or safety from a product. | Large randomized trials, long-term safety information, standardized preparations, and clinically validated indications remain absent from the cited evidence base. |
Canadian regulatory context
Health Canada’s advisory on unauthorized injectable peptide drugs provides general safety context. This page does not assess a product or recommend any intervention.
Evidence timeline
- 1
2010s: mitochondrial-derived peptide research expands
- 2
2020: human translational observations reported
- 3
Current: intervention and long-term safety evidence remains limited
Sources and maintenance
Sources are linked directly so readers can review the original material and its limitations.
- Human translational study
Primary research on MOTS-c biology and human context.
- Mitochondrial-derived peptide review
Review of evidence maturity and research questions.
- Health Canada public advisory
Official Canadian information on unauthorized injectable peptide drugs.